scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Jia-Qi Wang | Q94517861 |
P2093 | author name string | Yan-Ling Yang | |
Ting-Ting Luo | |||
Dong-Hui Wang | |||
Ya-Yun Wang | |||
Bao-Lin Guo | |||
Sheng-Ming Wang | |||
Chen-Xi Zheng | |||
Chun-Qiu Dai | |||
Shi-Cheng Luo | |||
Yun-Hu Bai | |||
P2860 | cites work | Construction and molecular analysis of gene transfer systems derived from bovine immunodeficiency virus | Q24529091 |
A viral assembly factor promotes AAV2 capsid formation in the nucleolus | Q24630650 | ||
Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10 | Q24796221 | ||
Intrathecal long-term gene expression by self-complementary adeno-associated virus type 1 suitable for chronic pain studies in rats | Q25256466 | ||
Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis | Q28213353 | ||
A third-generation lentivirus vector with a conditional packaging system | Q29616120 | ||
Virally mediated optogenetic excitation and inhibition of pain in freely moving nontransgenic mice | Q30576202 | ||
Efficient retrograde transport of adeno-associated virus type 8 to spinal cord and dorsal root ganglion after vector delivery in muscle | Q33691877 | ||
Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates. | Q33713108 | ||
AAV provides an alternative for gene therapy of the peripheral sensory nervous system | Q33822179 | ||
Comparison of AAV serotypes for gene delivery to dorsal root ganglion neurons | Q33822237 | ||
Syntaxin 8 modulates the post-synthetic trafficking of the TrkA receptor and inflammatory pain transmission | Q33888573 | ||
Antinociceptive effects of morphine and naloxone in mu-opioid receptor knockout mice transfected with the MORS196A gene. | Q33907197 | ||
Differential adeno-associated virus mediated gene transfer to sensory neurons following intrathecal delivery by direct lumbar puncture | Q33975660 | ||
Intrathecal delivery of a mutant micro-opioid receptor activated by naloxone as a possible antinociceptive paradigm. | Q34128898 | ||
Changes in expression of NMDA-NR1 receptor subunits in the rostral ventromedial medulla modulate pain behaviors | Q34147839 | ||
Intrathecal lentiviral-mediated RNA interference targeting PKCγ attenuates chronic constriction injury-induced neuropathic pain in rats | Q34150540 | ||
Adeno-associated virus vectorology, manufacturing, and clinical applications | Q34172314 | ||
Intraganglionic AAV6 results in efficient and long-term gene transfer to peripheral sensory nervous system in adult rats. | Q34684229 | ||
Gene delivery by lentivirus vectors | Q34688367 | ||
Immunological aspects of recombinant adeno-associated virus delivery to the mammalian brain | Q35000819 | ||
Gene therapy for neuropathic pain by silencing of TNF-α expression with lentiviral vectors targeting the dorsal root ganglion in mice | Q35123999 | ||
Development of a multipurpose GATEWAY-based lentiviral tetracycline-regulated conditional RNAi system (GLTR). | Q35170967 | ||
Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery | Q43685007 | ||
Globin Lentiviral Vector Insertions Can Perturb the Expression of Endogenous Genes in β-thalassemic Hematopoietic Cells | Q44154910 | ||
Remote nerve injection of mu opioid receptor adeno-associated viral vector increases antinociception of intrathecal morphine | Q44349594 | ||
Efficiencies of transgene expression in nociceptive neurons through different routes of delivery of adeno-associated viral vectors | Q44492885 | ||
Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain | Q44686125 | ||
Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS mice. | Q45377035 | ||
Neonatal intraperitoneal or intravenous injections of recombinant adeno-associated virus type 8 transduce dorsal root ganglia and lower motor neurons | Q45398907 | ||
Amelioration of chronic neuropathic pain after partial nerve injury by adeno-associated viral (AAV) vector-mediated over-expression of BDNF in the rat spinal cord | Q45855288 | ||
In vivo transduction of murine cerebellar Purkinje cells by HIV-derived lentiviral vectors | Q45856519 | ||
Intrathecal shRNA-AAV9 inhibits target protein expression in the spinal cord and dorsal root ganglia of adult mice | Q45879078 | ||
Transient growth factor delivery sustains regenerated axons after spinal cord injury. | Q45942523 | ||
Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease | Q46202469 | ||
Chronic catheterization of the spinal subarachnoid space | Q48344815 | ||
Lentiviral-mediated targeted transgene expression in dorsal spinal cord glia: tool for the study of glial cell implication in mechanisms underlying chronic pain development. | Q50660663 | ||
Design and evaluation of small interfering RNAs that target expression of the N-methyl-D-aspartate receptor NR1 subunit gene in the spinal cord dorsal horn. | Q50679314 | ||
Nerve injury-induced tactile allodynia is mediated via ascending spinal dorsal column projections. | Q51367356 | ||
Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. | Q51659718 | ||
Activation of spinal NF-κB/p65 contributes to peripheral inflammation and hyperalgesia in rat adjuvant-induced arthritis. | Q54182069 | ||
Transduction Patterns of Pseudotyped Lentiviral Vectors in the Nervous System | Q61970603 | ||
Efficient retrograde neuronal transduction utilizing self-complementary AAV1 | Q64376808 | ||
Adeno-associated viral vector gene expression in the adult rat spinal cord following remote vector delivery | Q64377268 | ||
Transduction of murine cerebellar neurons with recombinant FIV and AAV5 vectors | Q74285552 | ||
Lentiviral-mediated targeted NF-kappaB blockade in dorsal spinal cord glia attenuates sciatic nerve injury-induced neuropathic pain in the rat | Q79771972 | ||
Intraarticular induction of interleukin-1beta expression in the adult mouse, with resultant temporomandibular joint pathologic changes, dysfunction, and pain | Q83008500 | ||
Small interfering RNA-mediated knockdown of NF-κBp65 attenuates neuropathic pain following peripheral nerve injury in rats | Q83548572 | ||
Spinal delivery of analgesics in experimental models of pain and analgesia | Q35205465 | ||
Lentiviral gene transfer into the dorsal root ganglion of adult rats | Q35231284 | ||
In vivo contrast-enhanced MR imaging of direct infusion into rat peripheral nerves | Q35341325 | ||
The assembly-activating protein promotes capsid assembly of different adeno-associated virus serotypes | Q35531575 | ||
Glutamate Transporter GLT-1 Upregulation Attenuates Visceral Nociception and Hyperalgesia via Spinal Mechanisms Not Related to Anti-Inflammatory or Probiotic Effects. | Q35634837 | ||
Recombinant AAV-mediated gene delivery to the central nervous system. | Q35673387 | ||
Intracellular transport of recombinant adeno-associated virus vectors | Q35734826 | ||
The AAV vector toolkit: poised at the clinical crossroads | Q35876224 | ||
Adeno-associated virus vectors: potential applications for cancer gene therapy | Q36165834 | ||
Recombinant adeno-associated viral vectors in the nervous system | Q36184768 | ||
Sensory neuron targeting by self-complementary AAV8 via lumbar puncture for chronic pain | Q36458975 | ||
Virus-mediated shRNA knockdown of Na(v)1.3 in rat dorsal root ganglion attenuates nerve injury-induced neuropathic pain | Q36512520 | ||
Gene therapy for peripheral nervous system diseases | Q36985449 | ||
Recombinant adeno-associated virus serotype 6 (rAAV2/6)-mediated gene transfer to nociceptive neurons through different routes of delivery | Q37355740 | ||
Lentiviral vectors for gene transfer into the spinal cord glial cells | Q37401091 | ||
Sustained relief of neuropathic pain by AAV-targeted expression of CBD3 peptide in rat dorsal root ganglion | Q37434396 | ||
Chemokine contribution to neuropathic pain: respective induction of CXCL1 and CXCR2 in spinal cord astrocytes and neurons | Q37507494 | ||
AAV as a gene transfer vector for the treatment of neurological disorders: novel treatment thoughts for ALS. | Q37622300 | ||
Viral vectors for gene delivery to the central nervous system | Q37946113 | ||
Advances in lentiviral vectors: a patent review | Q38016461 | ||
Serotype-independent method of recombinant adeno-associated virus (AAV) vector production and purification | Q38071890 | ||
Mapping the AAV Capsid Host Antibody Response toward the Development of Second Generation Gene Delivery Vectors | Q38187651 | ||
Intraperitoneal administration of AAV9-shRNA inhibits target gene expression in the dorsal root ganglia of neonatal mice | Q39124150 | ||
Effective relief of neuropathic pain by adeno-associated virus-mediated expression of a small hairpin RNA against GTP cyclohydrolase 1. | Q39295701 | ||
Overexpression of GDNF in the uninjured DRG exerts analgesic effects on neuropathic pain following segmental spinal nerve ligation in mice. | Q39522270 | ||
High-titer, wild-type free recombinant adeno-associated virus vector production using intron-containing helper plasmids | Q39593544 | ||
SOCS3-mediated blockade of JAK/STAT3 signaling pathway reveals its major contribution to spinal cord neuroinflammation and mechanical allodynia after peripheral nerve injury | Q39712224 | ||
Simian immunodeficiency virus vector pseudotypes differ in transduction efficiency and target cell specificity in brain. | Q40111381 | ||
Amelioration of pain and histopathologic joint abnormalities in the Col1-IL-1beta(XAT) mouse model of arthritis by intraarticular induction of mu-opioid receptor into the temporomandibular joint. | Q40209479 | ||
Reversal of neurochemical changes and pain-related behavior in a model of neuropathic pain using modified lentiviral vectors expressing GDNF. | Q40310929 | ||
Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain | Q40329324 | ||
Overexpression of glial cell line-derived neurotrophic factor using a lentiviral vector induces time- and dose-dependent downregulation of tyrosine hydroxylase in the intact nigrostriatal dopamine system. | Q40532718 | ||
Intraneural convection enhanced delivery of AAVrh20 for targeting primary sensory neurons | Q40620767 | ||
Systematic determination of the packaging limit of lentiviral vectors | Q40776442 | ||
Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means | Q40859254 | ||
Defective RNA packaging is responsible for low transduction efficiency of CAEV-based vectors | Q41031358 | ||
Intrathecal lentivirus-mediated transfer of interleukin-10 attenuates chronic constriction injury-induced neuropathic pain through modulation of spinal high-mobility group box 1 in rats | Q42265950 | ||
miR-7a alleviates the maintenance of neuropathic pain through regulation of neuronal excitability. | Q42283334 | ||
Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes | Q42739394 | ||
Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus | Q42798600 | ||
Agrin downregulation induced by nerve injury contributes to neuropathic pain. | Q42822480 | ||
Comparative analysis of HIV-1-based lentiviral vectors bearing lyssavirus glycoproteins for neuronal gene transfer | Q43183949 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivatives | Q6937225 |
P433 | issue | 5 | |
P921 | main subject | genetic vector | Q427389 |
vector-borne disease | Q2083837 | ||
P1104 | number of pages | 12 | |
P304 | page(s) | 825-836 | |
P577 | publication date | 2017-11-17 | |
2018-05-01 | |||
P1433 | published in | The Anatomical Record | Q2725967 |
P1476 | title | Lentiviral vectors and adeno-associated virus vectors: useful tools for gene transfer in pain research | |
P478 | volume | 301 |
Q98177383 | A Review of Gene, Drug and Cell-Based Therapies for Usher Syndrome | cites work | P2860 |
Search more.